Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: A stock price vs MKL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MKL's multiple
Needs MKL P/E.
Implied fair value · at A's multiple
Needs A P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
AGILENT TECHNOLOGIES, INC. · implied price per share
Bear
$41.49
Base
$49.80
Bull
$60.61
MARKEL GROUP INC. · implied price per share
Bear
$2.56K
Base
$3.01K
Bull
$3.61K
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
THERMO FISHER SCIENTIFIC INC.
A vs TMO
ILLUMINA, INC.
A vs ILMN
BIO-TECHNE Corp
A vs TECH
BRUKER CORP
A vs BRKR
Azenta, Inc.
A vs AZTA
WATERS CORP /DE/
A vs WAT
TRAVELERS COMPANIES, INC.
A vs TRV
ALLSTATE CORP
A vs ALL
PROGRESSIVE CORP/OH/
A vs PGR
Chubb Ltd
A vs CB
EVEREST GROUP, LTD.
A vs EG
Edwyn research
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe A can sustain its 6.7% revenue growth and 52.4% gross margin while justifying a premium to MKL's much lower multiples, then hold or accumulate; otherwise, the data argues for caution because A is priced far above both MKL-implied value and the DCF range.
A trades at 31.9x P/E, 5.9x P/S, and 22.1x EV/EBITDA versus MKL at 11.1x, 1.5x, and 3.9x, respectively, implying a large valuation premium across earnings, sales, and cash-flow proxies. The current price of $145.97 is far above the P/E-implied price of $50.62 and also above the DCF range of $46.40-$62.78, while it sits slightly above the historical band midpoint and near the upper end of the historical range.
Supporting Metrics
